{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:03:20Z","timestamp":1786460600681,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Review question\/objective:<\/jats:title>\n                    <jats:p>The objective of this systematic review is to identify the effectiveness of sugammadex versus neostigmine on the reversal of rocuronium-induced neuromuscular blockade in surgical patients with myasthenia gravis undergoing general anesthesia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbisrir-2017-003624","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T18:43:42Z","timestamp":1539801822000},"page":"1922-1928","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of sugammadex versus neostigmine on restoration of neuromuscular function in surgical patients with myasthenia gravis undergoing rocuronium-induced neuromuscular blockade: a systematic review protocol"],"prefix":"10.11124","volume":"16","author":[{"given":"Elizabeth","family":"Yellott","sequence":"first","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, USA"},{"name":"The Louisiana Center for Promotion of Optimal Health Outcomes: a Joanna Briggs Institute Center of Excellence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Badeaux","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, USA"},{"name":"The Louisiana Center for Promotion of Optimal Health Outcomes: a Joanna Briggs Institute Center of Excellence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Martin","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, USA"},{"name":"The Louisiana Center for Promotion of Optimal Health Outcomes: a Joanna Briggs Institute Center of Excellence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie H.","family":"Schiavo","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, USA"},{"name":"The Louisiana Center for Promotion of Optimal Health Outcomes: a Joanna Briggs Institute Center of Excellence"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R1-20230825","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jclinane.2009.05.002","article-title":"Sugammadex: The first selective binding reversal agent for neuromuscular block","volume":"21","author":"Kovac","year":"2009","journal-title":"J Clin Anesth"},{"issue":"2","key":"R2-20230825","first-page":"49","article-title":"A review of the interest in sugammadex for deep neuromuscular blockade management in Belgium","volume":"64","author":"Dubois","year":"2013","journal-title":"Acta Anaesthesiol Belg"},{"issue":"1","key":"R3-20230825","first-page":"43","article-title":"Residual neuromuscular blockade","volume":"84","author":"Plummer-Roberts","year":"2016","journal-title":"AANA J"},{"issue":"1","key":"R4-20230825","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","article-title":"Current status of neuromuscular reversal and monitoring","volume":"126","author":"Brull","year":"2017","journal-title":"Anesthesiology"},{"key":"R5-20230825","first-page":"1","article-title":"VA Pharmacy Benefits Management Services, Medical Advisory Panel, VISN Pharmacist Executives","year":"2016","journal-title":"Sugammadex (BRIDION) National Drug Monograph"},{"key":"R6-20230825","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s40140-016-0155-8","article-title":"Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade","volume":"6","author":"Thilen","year":"2016","journal-title":"Curr Anesthesiol Rep"},{"issue":"1","key":"R8-20230825","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15280\/jlm.2016.6.1.43","article-title":"Rapid return of spontaneous respiration after general anesthesia with sugammadex in a patient with myasthenia gravis","volume":"6","author":"Kim","year":"2015","journal-title":"J Lifestyle Med"},{"issue":"2","key":"R9-20230825","first-page":"107","article-title":"Worldwide experience with sugammadex sodium: implications for the United States","volume":"83","author":"Welliver","year":"2015","journal-title":"AANA J"},{"issue":"12","key":"R12-20230825","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/anae.13277","article-title":"A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade","volume":"70","author":"Abad-Gurumeta","year":"2015","journal-title":"Anaesthesia"},{"issue":"3","key":"R13-20230825","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0259-1162.123211","article-title":"Sugammadex: a revolutionary drug in neuromuscular pharmacology","volume":"7","author":"Nag","year":"2013","journal-title":"Anesth Essays Res"},{"issue":"3","key":"R15-20230825","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic review of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"}],"container-title":["JBI Database of Systematic Reviews and Implementation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01938924-201810000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:58:25Z","timestamp":1786453105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01938924-201810000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.11124\/jbisrir-2017-003624","relation":{},"ISSN":["2202-4433"],"issn-type":[{"value":"2202-4433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}